生物可吸收血管支架市场按产品类型、材质、应用、最终用户和地区划分

预计到 2026 年，生物可吸收血管支架市场价值将达到 4.8 亿美元，预计到 2033 年将达到 9.6 亿美元，2026 年至 2033 年的复合年增长率为 8.5%。

生物可吸收血管支架（BVS）是一种用于治疗动脉阻塞的非金属网状管。与支架类似，它会随着阻塞动脉功能的恢復而逐渐溶解，使动脉恢復到自然状态。支架大约会在12到24个月内完全消失，为血管提供支撑直到其完全恢復功能。 BVS旨在疏通心臟阻塞的动脉，恢復心肌的血液供应。它们适用于各种心血管疾病患者。心血管手术常用的BVS包括聚左旋乳酸（PLLA）生物可吸收支架、金属生物可吸收支架及混合生物可吸收支架。

市场动态

冠状动脉疾病、缺血性心臟疾病和其他心血管疾病的高发生率推高了对生物可吸收血管支架的需求，预计这将推动市场成长。根据美国心臟协会理事会统计，2015年心血管疾病是全球首要死因，每年全球报告的死亡人数超过1,790万人。预计到2030年，这一数字将增至超过2,360万。根据同一资讯来源统计，2015年美国约有836,546人死于心血管疾病，约占总死亡人数的三分之一。

此外，主要企业正采取多种策略来巩固其市场地位，包括推出新产品、获得FDA核准、伙伴关係和联盟。例如，2016年7月，雅培公司获得美国食品药物管理局（FDA）对其生物可吸收心臟支架Absorb的核准。本产品是第一个完全可溶解的医疗设备支架。它将用于治疗美国冠状动脉疾病患者。

然而，血管成形术和冠状动脉疾病治疗中对血管移植装置的偏好是限制全球生物可吸收血管支架市场成长的主要因素之一。此外，严格的监管也阻碍了市场成长。

本次调查的主要特点

• 本报告对生物可吸收血管支架市场进行了详细分析，涵盖了预测期（2018-2026 年）内的市场规模和复合年增长率（%），以 2017 年为基准年。
• 该报告重点介绍了各个细分市场的潜在商机，并为该市场说明了一个有吸引力的投资提案矩阵。
• 该研究还提供了有关市场驱动因素、限制因素、机会、新产品发布或核准、市场趋势、区域展望以及主要企业采取的竞争策略的重要见解。
• 本报告根据以下参数介绍了全球生物可吸收血管支架市场主要企业的概况：公司概况、财务表现、产品系列、地理扩张、分销策略、关键发展和策略。
• 本报告的研究结果将使企业负责人和经营团队能够就即将推出的产品、政府措施、技术升级、市场扩张和行销策略做出明智的决策。
• 这份全球生物可吸收血管支架市场报告的目标受众包括投资者、产品製造商、经销商、供应商、研究和咨询公司、新参与企业和金融分析师等行业利益相关相关人员。

目录

第一章 研究目标与前提条件

• 调查目的
• 先决条件
• 简称

第二章 市场概览

• 报告概述
  • 市场定义和范围
• 执行摘要

第三章 市场动态、监理及趋势分析

• 市场动态
• 影响分析
• 主要亮点
• 法规环境
• 产品上市及核准情况
• PEST分析
• 波特分析
• 市场机会
• 法规环境
• 重大进展
• 产业趋势

4. 2020-2033年全球生物可吸收血管支架市场（依产品类型划分）

• 合成
• 生物来源

5. 2020-2033年全球生物可吸收血管支架市场（依材质划分）

• 金属基BVS
• 基于聚合物的BVS

6. 2020-2033年全球生物可吸收血管支架市场（依应用领域划分）

• 冠状动脉支架
• 週边动脉支架
• 其他的

7. 2020-2033年全球生物可吸收血管支架市场（依最终用户划分）

• 医院
• 门诊手术中心
• 心臟中心
• 其他的

8. 2020-2033年全球生物可吸收血管支架市场（依地区划分）

• 北美洲
  • 我们
  • 加拿大
• 拉丁美洲
  • 巴西
  • 阿根廷
  • 墨西哥
  • 其他拉丁美洲国家
• 欧洲
  • 德国
  • 英国
  • 西班牙
  • 法国
  • 义大利
  • 俄罗斯
  • 其他欧洲
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国
  • ASEAN
  • 亚太其他地区
• 中东
  • 海湾合作委员会国家
  • 以色列
  • 其他中东国家
• 非洲
  • 南非
  • 北非
  • 中非

第九章 竞争情势

• AngioDynamics, Inc.
• CR Bard, Inc.
• Teleflex Incorporated
• B. Braun Melsungen AG
• Medtronic Plc
• Vygon Ltd.
• Cook Medical Inc.
• Argon Medical Devices, Inc.
• ICU Medical, Inc.
• Theragenics Corporation

第十章 分析师建议

• 机会
• 分析师观点
• Coherent Opportunity Map

第十一章 参考文献与调查方法

• 参考
• 调查方法
• 关于本公司

Bioresorbable Vascular Scaffold Market is estimated to be valued at USD 480 Mn in 2026 and is expected to reach USD 960 Mn by 2033, growing at a compound annual growth rate (CAGR) of 8.5% from 2026 to 2033.

Bioresorbable vascular scaffold (BVS) is a nonmetallic mesh tube, which is used to treat blocked arteries. It is similar to a stent but gradually dissolves once the blocked artery starts functioning naturally again, enabling the artery to return to its natural state. The scaffold disappears in around 12-24 months and supports the vessel until it gain its full function. BVS is designed to help open up a blocked artery in the heart and restore blood flow to the heart muscle. It is used by patients who are suffering from different types of cardiovascular diseases. Some of the commonly used BVS for cardiac procedures include Poly-L-Lactide (PLLA) bioresorbable scaffold, metallic bioresorbable scaffold, and hybrid bioresorbable scaffold.

Market Dynamics

Increasing demand for bioresorbable vascular scaffold owing to high prevalence of coronary heart disease, ischemic heart disease, and other cardiovascular diseases is expected to drive market growth. According to American Heart Association Council, in 2015, cardiovascular disease was the leading cause of death in the world, accounting for over 17.9 million deaths per year globally, and this number is expected to increase to over 23.6 million by 2030. From the same source, cardiovascular diseases accounted for nearly 836,546 deaths in the U.S. in 2015, which is about 1 of every 3 deaths.

Moreover, key players are opting for different strategies such as new product launches, FDA approvals, partnerships, and collaborations to increase its foothold in the market. For instance, in July 2016, Abbott received the U.S. Food and Drug Administration approval for Absorb bioresorbable heart stent. This device is first-of-its-kind medical device with fully dissolving heart stents. This device will be available to treat people with coronary artery disease in the U.S.

However, preference for vascular graft devices for angioplasty and coronary artery diseases is one of the major factors restraining growth of the global bioresorbable vascular scaffold market. Furthermore, stringent regulatory scenario has also obstructed growth of the market.

Key features of the study

• This report provides in-depth analysis of the bioresorbable vascular scaffold market, market size (USD Mn), and compound annual growth rate (CAGR (%)) for the forecast period: 2018 - 2026, considering 2017 as the base year
• It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by leading players
• It profiles leading players in the global bioresorbable vascular scaffold market based on the following parameters - company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies
• Key players covered as a part of this study include Abbott Laboratories, Cook Medical, Boston Scientific Corporation, Stentys SA, MAQUET Holding B.V. & Co. KG (Getinge AB), W.L. Gore & Associates, Medtronic, C. R. Bard, Inc., B. Braun Melsungen AG, and Terumo Corporation among others
• Insights from this report would allow marketers and management authorities of companies to make informed decision with respect to their future product launches, governmental initiatives, technological up-gradation, market expansion, and marketing tactics
• The global bioresorbable vascular scaffold market report caters to various stakeholders in this industry, including investors, product manufacturers, distributors and suppliers for bioresorbable vascular scaffold market, research and consulting firms, new entrants, and financial analysts

Market Segmentation

• Product Type Insights (Revenue, USD Mn, 2026 - 2033)
  • Synthetic
  • Biological
• Material Type Insights (Revenue, USD Mn, 2026 - 2033)
  • Metal based BVS
  • Polymer based BVS
• Application Insights (Revenue, USD Mn, 2026 - 2033)
  • Coronary Artery Stents
  • Peripheral Artery Stent
  • Others
• End User Insights (Revenue, USD Mn, 2026 - 2033)
  • Hospitals
  • Ambulatory Surgical Centers
  • Cardiac center
  • Others
• Regional Insights (Revenue, USD Mn, 2026 - 2033)
  • North America
  • U.S.
  • Canada
  • Latin America
  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America
  • Europe
  • Germany
  • U.K.
  • France
  • Italy
  • Russia
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East
  • GCC
  • Israel
  • Rest of Middle East
  • Africa
  • North Africa
  • Central Africa
  • South Africa
• Key Players Insights
  • AngioDynamics, Inc.
  • C. R. Bard, Inc.
  • Teleflex Incorporated
  • B. Braun Melsungen AG
  • Medtronic Plc
  • Vygon Ltd.
  • Cook Medical Inc.
  • Argon Medical Devices, Inc.
  • ICU Medical, Inc.
  • Theragenics Corporation

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Overview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Global Bioresorbable Vascular Scaffold Market, By Product Type
  • Global Bioresorbable Vascular Scaffold Market, By Material
  • Global Bioresorbable Vascular Scaffold Market, By Application
  • Global Bioresorbable Vascular Scaffold Market, By End User
  • Global Bioresorbable Vascular Scaffold Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
• Impact Analysis
• Key Highlights
• Regulatory Scenario
• Product Launches/Approvals
• PEST Analysis
• PORTER's Analysis
• Market Opportunities
• Regulatory Scenario
• Key Developments
• Industry Trend

4. Global Bioresorbable Vascular Scaffold Market, By Product Type, 2020-2033, (USD Mn)

• Introduction
  • Market Share Analysis, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, 2021 - 2033
  • Segment Trends
• Synthetic
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2033, (USD Mn)
• Biological
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2033, (USD Mn)

5. Global Bioresorbable Vascular Scaffold Market, By Material Type, 2020-2033, (USD Mn)

• Introduction
  • Market Share Analysis, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, 2021 - 2033
  • Segment Trends
• Metal based BVS
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2033, (USD Mn)
• Polymer based BVS
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2033, (USD Mn)

6. Global Bioresorbable Vascular Scaffold Market, By Application Type, 2020-2033, (USD Mn)

• Introduction
  • Market Share Analysis, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, 2021 - 2033
  • Segment Trends
• Coronary Artery Stents
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2033, (USD Mn)
• Peripheral Artery Stent
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2033, (USD Mn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2033, (USD Mn)

7. Global Bioresorbable Vascular Scaffold Market, By End User, 2020-2033, (USD Mn)

• Introduction
  • Market Share Analysis, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, 2021 - 2033
  • Segment Trends
• Hospitals
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2033, (USD Mn)
• Ambulatory Surgical Centers
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2033, (USD Mn)
• Cardiac center
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2033, (USD Mn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2033, (USD Mn)

8. Global Bioresorbable Vascular Scaffold Market, By Region, 2020 - 2033, Value (USD Mn)

• Introduction
  • Market Share (%) Analysis, 2026, 2028 & 2033, Value (USD Mn)
  • Market Y-o-Y Growth Analysis (%), 2021 - 2033, Value (USD Mn)
  • Regional Trends
• North America
  • Introduction
  • Market Size and Forecast, By Product Type, 2020 - 2033, Value (USD Mn)
  • Market Size and Forecast, By Material Type, 2020 - 2033, Value (USD Mn)
  • Market Size and Forecast, By Application, 2020 - 2033, Value (USD Mn)
  • Market Size and Forecast, By End User, 2020 - 2033, Value (USD Mn)
  • Market Size and Forecast, By Country, 2020 - 2033, Value (USD Mn)
    • U.S.
    • Canada
• Latin America
  • Introduction
  • Market Size and Forecast, By Product Type, 2020 - 2033, Value (USD Mn)
  • Market Size and Forecast, By Material Type, 2020 - 2033, Value (USD Mn)
  • Market Size and Forecast, By Application, 2020 - 2033, Value (USD Mn)
  • Market Size and Forecast, By End User, 2020 - 2033, Value (USD Mn)
  • Market Size and Forecast, By Country, 2020 - 2033, Value (USD Mn)
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
• Europe
  • Introduction
  • Market Size and Forecast, By Product Type, 2020 - 2033, Value (USD Mn)
  • Market Size and Forecast, By Material Type, 2020 - 2033, Value (USD Mn)
  • Market Size and Forecast, By Application, 2020 - 2033, Value (USD Mn)
  • Market Size and Forecast, By End User, 2020 - 2033, Value (USD Mn)
  • Market Size and Forecast, By Country, 2020 - 2033, Value (USD Mn)
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, By Product Type, 2020 - 2033, Value (USD Mn)
  • Market Size and Forecast, By Material Type, 2020 - 2033, Value (USD Mn)
  • Market Size and Forecast, By Application, 2020 - 2033, Value (USD Mn)
  • Market Size and Forecast, By End User, 2020 - 2033, Value (USD Mn)
  • Market Size and Forecast, By Country, 2020 - 2033, Value (USD Mn)
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
• Middle East
  • Introduction
  • Market Size and Forecast, By Product Type, 2020 - 2033, Value (USD Mn)
  • Market Size and Forecast, By Material Type, 2020 - 2033, Value (USD Mn)
  • Market Size and Forecast, By Application, 2020 - 2033, Value (USD Mn)
  • Market Size and Forecast, By End User, 2020 - 2033, Value (USD Mn)
  • Market Size and Forecast, By Country, 2020 - 2033, Value (USD Mn)
    • GCC Countries
    • Israel
    • Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, By Product Type, 2020 - 2033, Value (USD Mn)
  • Market Size and Forecast, By Material Type, 2020 - 2033, Value (USD Mn)
  • Market Size and Forecast, By Application, 2020 - 2033, Value (USD Mn)
  • Market Size and Forecast, By End User, 2020 - 2033, Value (USD Mn)
  • Market Size and Forecast, By Country, 2020 - 2033, Value (USD Mn)
    • South Africa
    • North Africa
    • Central Africa

9. Competitive Landscape

• AngioDynamics, Inc.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• C. R. Bard, Inc.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Teleflex Incorporated
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• B. Braun Melsungen AG
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Medtronic Plc
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Vygon Ltd.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Cook Medical Inc.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Argon Medical Devices, Inc.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• ICU Medical, Inc.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Theragenics Corporation
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies

10. Analyst Recommendations

• Wheel of Fortune
• Analyst View
• Coherent Opportunity Map

11. References and Research Methodology

• References
• Research Methodology
• About us